Coloplast ROE 2014-2019 | CLPBY
Current and historical return on equity (ROE) values for Coloplast (CLPBY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Coloplast ROE for the three months ending March 31, 2019 was 70.05%.
|Coloplast ROE - Return on Equity Historical Data
||TTM Net Income
||Return on Equity
||Medical Products Manufacturing
Coloplast A/S develops and provides health care products and services. Its operating business segments consist of Chronic Care, Urology Care and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Urology Care segment offers urological products, including disposable products. The Wound and Skin Care segment covers the sale of wound and skin care products. Coloplast A/S is headquartered in Humlebaek, Denmark.